Monogram Biosciences, Inc. (MGRM) Wrap Up:

Monogram Biosciences, Inc., a life sciences company, engages in the development and commercialization of molecular diagnostic products for the treatment of infectious diseases, cancer, and other diseases in the United States. Its products for infectious diseases include PhenoSense HIV that directly and quantitatively measures resistance of a patient’s HIV to anti-viral drugs and measures viral fitness, or the ability of a virus to reproduce and infect new cells; GeneSeq HIV for examining and evaluating the genetic sequences of a patient’s HIV; PhenoSense GT, which is a combination of the PhenoSense HIV and GeneSeq HIV tests; PhenoSense HIV Entry that measures resistance of a patient’s HIV to...